Gene · 406909
Papers2,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNAs in Parkinson's disease: a systematic review and diagnostic accuracy meta-analysis. | Sci Rep | 2023 | 37770507 | PubTator, text mining | PubMed |
| [Predictive value of plasma exosomal miR-124-3p for the risk of chronic cerebral hypoperfusion]. | Zhonghua Nei Ke Za Zhi | 2023 | 37766438 | PubTator, text mining | PubMed |
| The Role of Microglial Exosomes and miR-124-3p in Neuroinflammation and Neuronal Repair after Traumatic Brain Injury. | Life (Basel) | 2023 | 37763327 | PubTator, text mining | PubMed |
| ITCH-Mediated Ubiquitylation of ITGB3 Promotes Cell Proliferation and Invasion of Ectopic Endometrial Stromal Cells in Ovarian Endometriosis. | Biomedicines | 2023 | 37760946 | PubTator, text mining | PubMed |
Investigation of Tumor Heterogeneity Using Integrated Single-Cell RNA Sequence Analysis to Focus on Genes Related to Breast Cancer-, EMT-, CSC-, and Metastasis-Related Markers in Patients with HER2-Positive Breast Cancer. | Cells | 2023 | 37759508 | PubTator, text mining | PubMed |
| A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma-From m6A Modification to Blood Biomarkers. | Cells | 2023 | 37759495 | PubTator, text mining | PubMed |
| Non-Coding RNA in Microglia Activation and Neuroinflammation in Alzheimer's Disease. | J Inflamm Res | 2023 | 37753266 | PubTator, text mining | PubMed |
| An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment. | Front Immunol | 2023 | 37753074 | PubTator, text mining | PubMed |
| Epigenetic regulation of programmed cell death in hypoxia-induced pulmonary arterial hypertension. | Front Immunol | 2023 | 37753070 | PubTator, text mining | PubMed |
| The role of microRNAs in neurobiology and pathophysiology of the hippocampus. | Front Mol Neurosci | 2023 | 37727513 | PubTator, text mining | PubMed |
| Genetic Influences on Outcomes of Psychotherapy in Borderline Personality Disorder: A Narrative Review of Implications for Personalized Treatment. | Cureus | 2023 | 37724239 | PubTator, text mining | PubMed |
| Non-coding RNAs are key players and promising therapeutic targets in atherosclerosis. | Front Cell Dev Biol | 2023 | 37719883 | PubTator, text mining | PubMed |
| miR-124-3p target genes identify globus pallidus role in suicide ideation recovery in borderline personality disorder. | Npj Ment Health Res | 2023 | 37712050 | PubTator, text mining | PubMed |
| Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance. | J Transl Med | 2023 | 37705098 | PubTator, text mining | PubMed |
| Research progress on the role of extracellular vesicles in neurodegenerative diseases. | Transl Neurodegener | 2023 | 37697342 | PubTator, text mining | PubMed |
| Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease. | Lipids Health Dis | 2023 | 37697333 | PubTator, text mining | PubMed |
| Development of Shortened miR-506-3p Mimics Exhibiting Strong Differentiation-Inducing Activity in Neuroblastoma Cells. | Molecules | 2023 | 37687123 | PubTator, text mining | PubMed |
| Epigenetic Downregulation of Hsa-miR-193b-3p Increases Cyclin D1 Expression Level and Cell Proliferation in Human Meningiomas. | Int J Mol Sci | 2023 | 37686289 | PubTator, text mining | PubMed |
| Identification of potential molecular mechanisms and therapeutic targets for recurrent pelvic organ prolapse. | Heliyon | 2023 | 37681155 | PubTator, text mining | PubMed |
| The landscape of lncRNAs in gastric cancer: from molecular mechanisms to potential clinical applications. | Front Pharmacol | 2023 | 37670949 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406909/papers?page=15